Your browser doesn't support javascript.
loading
Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results.
J Drugs Dermatol ; 19(11): 1093-1100, 2020 Nov 01.
Article in En | MEDLINE | ID: mdl-33196758

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Scalp Dermatoses / Morpholines / Protein Kinase Inhibitors / Keratosis, Actinic / Secondary Prevention / Acetamides Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2020 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Scalp Dermatoses / Morpholines / Protein Kinase Inhibitors / Keratosis, Actinic / Secondary Prevention / Acetamides Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2020 Document type: Article Country of publication: United States